The purpose of this study is to learn more about how often targeted therapy affects the radioiodine (RAI) absorption by thyroid cancer. This will be done through scans done at an initial visit and one week later. The study team will then compare the levels of RAI from both sets of images to see if there is a change. Participation will be complete after this week.
If you are interested in participating, please contact us!